Atorvastatin (as calcium) 10 mg – 20mg.

20 Film Coated Tablets.

HMG-CoA reductase inhibitors.


Lipid Lowering Drugs


Atorvatin® (Atorvastatin calcium) is a synthetic lipid-lowering agent.

Atorvatin® is indicated:
- As an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels and to increase HDL-C in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Fredrickson Types IIa and IIb).
- As an adjunct to diet for the treatment of patients with elevated serum TG levels (Fredrickson Type IV).
- For the treatment of patients with primary dysbetalipoproteinemia (Fredrickson Type III) who do not respond adequately to diet.
- To reduce total-C and LDL-C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatments (eg, LDL apheresis) or if such treatments are unavailable.
- As an adjunct to diet to reduce total-C, LDL-C, and apo B levels in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial percholesterolemia.


Aleppo Pharmaceutical Company (ALPHA) is Syria's leading manufacturer and distributor of pharmaceutical products. Providing high quality products according to GMP requirements; regulations and ISO 9002 (Quality Management System).

Syrian Pharmaceutical Industries, Middle East, Syria Pharmaceutical Industry, pharmacy, Medicaments, medical, Drugs, arab pharmaceutical manufacturing, pharmaceutical companies, pharmaceutical sales.

If you have any questions about Atorvatin® that have not been answered on this site send us an email or call ALPHA Pharmaceutical Industry at + 963-21-2122424.

Copyright © ALPHA – Aleppo Pharmaceutical Industries, Aleppo-Syria - Atorvatin®. All rights reserved
Web Design by Syrian Web Solutions